{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:40:54Z","timestamp":1771630854829,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81502993"],"award-info":[{"award-number":["81502993"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"doctoral Research Funding of Liaoning Province","award":["20141066"],"award-info":[{"award-number":["20141066"]}]},{"name":"General Project in Education Department of Liaoning Province","award":["L2014379"],"award-info":[{"award-number":["L2014379"]}]},{"name":"Scientific Research Foundation","award":["QNJJ2013504"],"award-info":[{"award-number":["QNJJ2013504"]}]},{"name":"Career Development Program for Young Teachers in Shenyang Pharmaceutical University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.colsurfb.2016.07.051","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T22:42:11Z","timestamp":1469832131000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers"],"prefix":"10.1016","volume":"147","author":[{"given":"Simeng","family":"Mu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-0731","authenticated-orcid":false,"given":"Zhonggui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2016.07.051_bib0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.colsurfb.2015.02.039","article-title":"Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin","volume":"128","author":"Guo","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2013.01.019","article-title":"Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size","volume":"453","author":"Sinha","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajps.2014.12.006","article-title":"Overview of milling techniques for improving the solubility of poorly water-soluble drugs","volume":"10","author":"Loh","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0020","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jps.24266","article-title":"Systematic screening of different surface modifiers for the production of physically stable nanosuspensions","volume":"104","author":"Lestari","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-0987(02)00251-8","article-title":"Nanosizing: a formulation approach for poorly-water-soluble compounds","volume":"18","author":"Merisko-Liversidge","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2008.12.030","article-title":"Production and characterization of Hesperetin nanosuspensions for dermal delivery","volume":"371","author":"Mishra","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jps.23335","article-title":"Development of curcumin nanocrystal: physical aspects","volume":"102","author":"Rachmawati","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0040","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","article-title":"Stability of nanosuspensions in drug delivery","volume":"172","author":"Wang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","article-title":"Drug nanocrystals: in vivo performances","volume":"160","author":"Gao","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.colsurfb.2015.05.010","article-title":"Comparative studies of the in vitro dissolution and in vivo pharmacokinetics for different formulation strategies (solid dispersion, micronization, and nanocrystals) for poorly water-soluble drugs: a case study for lacidipine","volume":"132","author":"Fu","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14227\/DT110204P16","article-title":"Dissolution media simulating fasted and fed states","volume":"11","author":"Marques","year":"2004","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10973-007-8390-3","article-title":"Thermal behavior of orthorhombic polymorphs I and II of spironolactone","volume":"90","author":"Espeau","year":"2007","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajps.2014.09.006","article-title":"Enhanced bioavailability of rebamipide nanocrystal tablets: formulation and in vitro\/in vivo evaluation","volume":"10","author":"Guo","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0070","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.2147\/IJN.S48597","article-title":"A novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorption","volume":"8","author":"Gao","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13204-012-0188-3","article-title":"Nanosuspension for enhancement of oral bioavailability of felodipine","volume":"4","author":"Sahu","year":"2014","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jct.2014.07.011","article-title":"Determination and correlation of solubility of spironolactone form II in pure solvents and binary solvent mixtures","volume":"79","author":"Zhang","year":"2014","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2009.09.030","article-title":"Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension","volume":"383","author":"Kakran","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molstruc.2007.07.043","article-title":"Study of interaction of spironolactone with hydroxypropyl-\u03b2-cyclodextrin in aqueous solution and in solid state","volume":"878","author":"Rajabi","year":"2008","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0095","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.2147\/IJN.S87143","article-title":"Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation","volume":"10","author":"Liu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2010.02.013","article-title":"Understanding the structure and stability of paclitaxel nanocrystals","volume":"390","author":"Deng","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1081\/DDC-100107676","article-title":"A nifedipine coground mixture with sodium deoxycholate. II. Dissolution characteristics and stability","volume":"27","author":"Suzuki","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2014.06.015","article-title":"Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease","volume":"472","author":"Palmeiro-Roldan","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0115","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1021\/bi00438a033","article-title":"Oxidative metabolism of spironolactone: evidence for the involvement of electrophilic thiosteroid species in drug-mediated destruction of rat hepatic cytochrome P450","volume":"28","author":"Decker","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)38305-9","article-title":"Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite","volume":"266","author":"Cook","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijpharm.2008.05.019","article-title":"The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat","volume":"361","author":"Shayeganpour","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2015.08.066","article-title":"Characterization and biological properties of NanoCUR formulation and its effect on major human cytochrome P450 enzymes","volume":"495","author":"Shamsi","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0135","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02652048.2013.788090","article-title":"Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution","volume":"31","author":"Beloqui","year":"2014","journal-title":"J. Microencapsulation"},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00500971","article-title":"Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man","volume":"300","author":"Abshagen","year":"1977","journal-title":"N. S. Arch. Pharmacol."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/c0fo00080a","article-title":"Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides","volume":"1","author":"Gunness","year":"2010","journal-title":"Food Funct."},{"key":"10.1016\/j.colsurfb.2016.07.051_bib0155","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3945\/jn.109.118349","article-title":"Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters","volume":"140","author":"Bartley","year":"2010","journal-title":"J. Nutr."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776516305537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776516305537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:37:03Z","timestamp":1749029823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776516305537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"alternative-id":["S0927776516305537"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2016.07.051","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2016.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}